- U. S. Food and Drug Administration
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the
- What We Do | FDA
FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats
- Warning Letters | FDA
Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the
- Drug Approvals and Databases | FDA
Novel Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products Drug and Biologic Approval and IND Activity Reports This Week's Drug Approvals Drug Trials Snapshots
- FDA Newsroom | FDA
The latest news and events at the U S Food and Drug Administration (FDA) and resources for journalists
- FDA Dashboards - Inspections
FDA does not issue CGMP certificates at the conclusion of an inspection Instead, this dashboard provides the outcomes, including classification and other details, of a firm’s most recent inspection
- Novel Drug Approvals for 2025 | FDA
To see the FDA-approved conditions of use [e g , indication (s), population (s), dosing regimen (s)] for each of these products, please see the most recently approved Prescribing Information (or
- Inspection Classification Database | FDA
The Food and Drug Administration (FDA) inspects and assesses regulated facilities to determine a firm's compliance with applicable laws and regulations, such as the Food, Drug, and Cosmetic Act
|